Brief: Ipsen Confirms Financial Guidance For 2024
April 24 (Reuters) - Ipsen SA IPN.PA :
* CONFIRMATION OF FINANCIAL GUIDANCE FOR 2024
* Q1 TOTAL-SALES GROWTH OF 13.3% AT CER(1), OR 10.9% AS
REPORTED,
DRIVEN BY 16.2%(1) INCREASE IN SALES OF GROWTH PLATFORMS
Source text for Eikon: ID:nGNE5jc9nG
Further company coverage: IPN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Ipsen SA
See all newsFulcrum falls after discontinuing sickle cell drug program
Fulcrum falls after discontinuing sickle cell drug program
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns
Fulcrum Therapeutics falls after scrapping sickle cell drug development
Brief: Ipsen's IQIRVO Shows Meaningful Fatigue Improvements In Moderate-To-Severe PBC Patients